CARLISLE COS INC
CSLNYSE🏆 #666 by market capEarnings Oct 28US Equity
$345.55▼ $3.03 (−0.87%)
🌙 After hours$336.02▼ 2.76%Regular close · extended-hours price shownTrack CSL
Get earnings, price moves & breaking news on Telegram
24h▼ 0.9%
7d▼ 2.0%
14d▲ 3.1%
30d▲ 6.1%
ytd▲ 8.1%
1y▲ 4.4%
🏦Market Cap
$13.72B
Mid Cap
📈Revenue Growth (YoY)
1.9%
Slowing
📊Gross Margin
35.3%
Healthy
💵FCF Margin
18.4%
Healthy
⚖️P/S Ratio
2.7x
Cheap
Otter Score
72
Strong
CARLISLE COS INC
CSLAnalyst Ratings
Price
$345.55
Total
26
Raised
3
Lowered
4
Avg PT
$383.50
H / L
$412 / $355
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Baird | Reiterated | Outperform | 2026-10-13 | — | — |
Truist Securities | Reiterated | Hold | 2026-07-07 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-04-24 | $425.00 | +23.00% |
JP Morgan | Reiterated | Overweight | 2026-03-09 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-10-13 | $455.00 | +31.70% |
Loop Capital | Downgraded | Buy → Hold | 2025-07-31 | — | — |
Zelman & Assoc | Upgraded | Underperform → Neutral | 2025-04-14 | — | — |
Jefferies | Downgraded | Buy → Hold | 2023-09-26 | — | — |
BMO Capital | Reiterated | Outperform | 2023-05-01 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-04-11 | — | — |
Zelman | Reiterated | Buy | 2021-11-15 | — | — |
Northcoast Research | Upgraded | Neutral → Buy | 2021-06-30 | — | — |
Longbow Research | Downgraded | Buy → Neutral | 2021-04-12 | — | — |
Berenberg | Reiterated | Buy | 2020-01-14 | — | — |
Buckingham Research | Downgraded | Buy → Neutral | 2019-07-08 | — | — |
B. Riley FBR | Reiterated | Buy | 2018-10-24 | — | — |
B. Riley Securities | Reiterated | Buy | 2018-10-24 | — | — |
Buckingham | Reiterated | Buy | 2017-09-05 | — | — |
Topeka | Reiterated | Buy | 2016-05-26 | — | — |
Wunderlich | Reiterated | Buy | 2015-12-16 | — | — |
KeyBanc | Reiterated | Sector Weight → Equal Weight | 2015-09-29 | — | — |
RBC Capital | Reiterated | Sector Perform → Perform | 2014-11-25 | — | — |
Keybanc | Reiterated | Buy | 2014-08-29 | — | — |
FBR Capital | Reiterated | Market Perform | 2014-04-15 | — | — |
SunTrust Robinson Humphrey | Upgraded | Neutral → Buy | 2013-07-24 | — | — |
Citigroup | Reiterated | Neutral | 2013-04-25 | — | — |
Institution
Baird
Reiterated · Outperform · 2026-10-13
—
—
Truist Securities
Reiterated · Hold · 2026-07-07
—
—
Oppenheimer
Reiterated · Outperform · 2026-04-24
$425.00
+23.00%
JP Morgan
Reiterated · Overweight · 2026-03-09
—
—
Goldman Sachs
Reiterated · Buy · 2025-10-13
$455.00
+31.70%
Loop Capital
Downgraded · Buy → Hold · 2025-07-31
—
—
Zelman & Assoc
Upgraded · Underperform → Neutral · 2025-04-14
—
—
Jefferies
Downgraded · Buy → Hold · 2023-09-26
—
—
BMO Capital
Reiterated · Outperform · 2023-05-01
—
—
Credit Suisse
Reiterated · Outperform · 2023-04-11
—
—
Zelman
Reiterated · Buy · 2021-11-15
—
—
Northcoast Research
Upgraded · Neutral → Buy · 2021-06-30
—
—
Longbow Research
Downgraded · Buy → Neutral · 2021-04-12
—
—
Berenberg
Reiterated · Buy · 2020-01-14
—
—
Buckingham Research
Downgraded · Buy → Neutral · 2019-07-08
—
—
B. Riley FBR
Reiterated · Buy · 2018-10-24
—
—
B. Riley Securities
Reiterated · Buy · 2018-10-24
—
—
Buckingham
Reiterated · Buy · 2017-09-05
—
—
Topeka
Reiterated · Buy · 2016-05-26
—
—
Wunderlich
Reiterated · Buy · 2015-12-16
—
—
KeyBanc
Reiterated · Sector Weight → Equal Weight · 2015-09-29
—
—
RBC Capital
Reiterated · Sector Perform → Perform · 2014-11-25
—
—
Keybanc
Reiterated · Buy · 2014-08-29
—
—
FBR Capital
Reiterated · Market Perform · 2014-04-15
—
—
SunTrust Robinson Humphrey
Upgraded · Neutral → Buy · 2013-07-24
—
—
Citigroup
Reiterated · Neutral · 2013-04-25
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space